Stocks and Investing Stocks and Investing
Mon, November 27, 2023

Raghuram Selvaraju Maintained (TRDA) at Strong Buy with Decreased Target to $20 on, Nov 27th, 2023


Published on 2024-10-28 07:44:10 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Entrada Therapeutics, Inc." (TRDA) at Strong Buy with Decreased Target from $25 to $20 on, Nov 27th, 2023.

Raghuram, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources